importation of lactose free long acting beta 2 agonist inhalers l.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
Importation of Lactose Free Long Acting Beta-2 Agonist Inhalers PowerPoint Presentation
Download Presentation
Importation of Lactose Free Long Acting Beta-2 Agonist Inhalers

Loading in 2 Seconds...

play fullscreen
1 / 6

Importation of Lactose Free Long Acting Beta-2 Agonist Inhalers - PowerPoint PPT Presentation


  • 589 Views
  • Uploaded on

Importation of Lactose Free Long Acting Beta-2 Agonist Inhalers. Lynda Mitchell, M.A. Parents of Food Allergic Kids (POFAK) LMITCHELL@kidswithfoodallergies.org. Current Situation. Cow’s milk allergy affects over 4.6 million in the U.S. Asthma affects over 20 million in the U.S.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Importation of Lactose Free Long Acting Beta-2 Agonist Inhalers' - jaden


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
importation of lactose free long acting beta 2 agonist inhalers

Importation of Lactose Free Long Acting Beta-2 Agonist Inhalers

Lynda Mitchell, M.A.

Parents of Food Allergic Kids (POFAK)

LMITCHELL@kidswithfoodallergies.org

current situation
Current Situation
  • Cow’s milk allergy affects over 4.6 million in the U.S.
  • Asthma affects over 20 million in the U.S.
  • NAEPP guidelines for certain classifications of asthma recommend the use of long acting beta-2 agonist inhalers for optimal management
current situation3
Current Situation
  • Lactose-free long acting beta 2 agonist inhalers are no longer available in the U.S.; they have been replaced with CFC-free diskus inhalers that contain lactose and trace milk protein that some severely milk allergic asthmatics cannot use
  • The same manufacturers still produce the lactose free inhalers versions of these inhalers for the Canadian market
current alternatives
Current Alternatives
  • Receive sub-optimal asthma treatment that is not in conformance with NAEPP best practice recommendations
  • Purchase lactose free inhalers illegally and out of pocket from Canada that are the same as the ones previously available in the U.S.
solution
Solution
  • In situations such as this, where a drug previously FDA approved as safe and effective is no longer available in the U.S. but is available in Canada, importation should be legal, allowable and reimbursable just as when that drug was available in the U.S. market.
references
References

1 Besler, M., Eignenmann, P. &Schwartz, R. (2002). Allergen Data Collection - Update: Cow's Milk  (Bos domesticus). Internet Symposium on Food Allergens. Retrieved on March 24, 2004 from http://www.food-allergens.de/symposium-4-1/cows-milk/cows-milk-abstract.html

2 Nowak-Wegrzyn, A. (2003, June). Future Approaches to Food Allergy. Pediatrics. Retrieved on March 24, 2004 from http://pediatrics.aappublications.org/cgi/content/full/111/6/S2/1672

3 National Center for Health Statistics, Centers for Disease Control and Prevention. Asthma Prevalence, Health Care Use, and Mortality, 2000-2001.

4 National Asthma Education and Prevention Program. (NAEPP)(2002). Quick reference NAEPP expert panel report for the diagnosis and management of asthma – update on selected topics for 2002. Retrieved on March 24, 2004 from http://www.nhlbi.nih.gov/guidelines/asthma/execsumm.pdf

5 Center for Drug Evaluation and Research, U.S. Food and Drug Administration. (2001). Metered-Dose Inhaler Medication: Frequently asked questions. Retrieved on March 24, 2004 from http://www.fda.gov/cder/mdi/mdifaqs.htm

6 Glaxo Smith Kline, Inc. (2003). [Product inserts] Retrieved March 23, 2004 from http://us.gsk.com/products/assets/us_advair.pdf, and http://us.gsk.com/products/assets/us_serevent_diskus.pdf

7 Fiocchi A, Restani P, Leo G, Martelli A, Bouygue GR, Terracciano L, Ballabio C, & Valsasina R. (2003, August). Clinical tolerance to lactose in children with cow's milk allergy. Pediatrics. Retrieved on March 23, 2003 from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12897287

8 Nowak-Wegrzyn, A., Shapiro, G.G., Beyer, K., Bardina, L., & Sampson, H.A. (2004, March). Contamination of dry powder inhalers for asthma with milk proteins containing lactose. Journal of Allergy and Clinical Immunology. [Letter to the Editor] Retrieved on March 23, 2004 from http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=letter&id=as0091674903026770

9 Nowak-Wegrzyn, A., Shapiro, G.G., Beyer, K., Bardina, L., & Sampson, H.A. (2004, March). Contamination of dry powder inhalers for asthma with milk proteins containing lactose. Journal of Allergy and Clinical Immunology. [Letter to the Editor] Retrieved on March 23, 2004 from http://www2.us.elsevierhealth.com/scripts/om.dll/serve?action=searchDB&searchDBfor=art&artType=letter&id=as0091674903026770